Vesper Biotechnologies ApS
1 clinical trials · Sponsor
◉ Watch Vesper Biotechnologies ApS
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants (NCT06226064) | Vesper Biotechnologies ApS | 2023-10-11 |
Track Vesper Biotechnologies ApS automatically
Every clearance here is in the API, with alerts when new ones post.